Moreover, cleavage resistant mutant MerTK enhances NASH fibrosis, while all-trans retinoic acids block MerTK activation via ADAM17-induced cleavage, resulting in suppression of NASH progression (Cai et al., 2020). This evidence concerns the gene MERTK and metabolic dysfunction-associated steatohepatitis.